Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects. [electronic resource]
Producer: 20110520Description: 163-72 p. digitalISSN:- 1600-051X
- Absorbable Implants
- Adult
- Aged
- Alveolar Bone Loss -- drug therapy
- Area Under Curve
- Becaplermin
- Biocompatible Materials -- therapeutic use
- Bone Regeneration -- drug effects
- Bone Substitutes -- therapeutic use
- Calcium Phosphates -- therapeutic use
- Double-Blind Method
- Drug Combinations
- Female
- Follow-Up Studies
- Guided Tissue Regeneration, Periodontal -- methods
- Humans
- Male
- Middle Aged
- Periodontal Diseases -- drug therapy
- Platelet-Derived Growth Factor -- physiology
- Proto-Oncogene Proteins c-sis
- Recombinant Proteins
- Statistics, Nonparametric
- Tissue Scaffolds
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.